UNITED STATES ANTIMONY CORP (UAMY) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
UAMY currently has 142M outstanding shares. with moderate dilution risk from 45.8M authorized shares representing 32.3% potential dilution. The company has significantly diluted shareholders by 30.53% over the past 2 years, indicating aggressive capital raising.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 14, 2026 |
10-Q filing | 141.6M shares outstanding |
140M | 46M |
| Mar 19, 2026 |
10-K filing | 143.4M shares outstanding |
140M | 44M |
| Nov 12, 2025 |
10-Q filing | 140.0M shares outstanding |
140M | 67M |
| Aug 12, 2025 |
10-Q filing | 118.3M shares outstanding |
120M | 89M |
| May 08, 2025 |
10-Q filing | 113.7M shares outstanding |
110M | 94M |
| Apr 23, 2025 |
S-3/A filing: United States Antimony Corporation may offer and sell shares of common stock, shares of preferred stock, warrants and rights to purchase common stock, preferred stock or units, as well as units that include any of these securities, with an aggregate offering price of up to $100,000,000. |
110M | 79M |
| Apr 18, 2025 |
S-3/A filing: The filing registers an indeterminate number of shares of common stock and preferred stock, an indeterminate principal amount of debt securities, an indeterminate number of warrants, rights to purchase common stock, preferred stock or debt securities, and an indeterminate number of units, as shall have an aggregate initial offering price not to exceed $100,000,000. |
110M | 99M |
| Mar 20, 2025 |
10-K filing | 108.6M shares outstanding |
110M | 99M |
| Dec 27, 2024 |
S-3 filing: The company is filing an S-3 to register the offering and sale of up to $100,000,000 of common stock, preferred stock, warrants, rights to purchase common stock or preferred stock, or units. |
110M | 99M |
| Nov 29, 2024 |
S-3 filing: The selling stockholders may, from time to time, offer and resell under this prospectus up to 10,060,500 shares of common stock, which are issuable upon the exercise of warrants. |
110M | 46M |
| Nov 12, 2024 |
10-Q filing | 107.6M shares outstanding |
110M | 36M |
| Aug 09, 2024 |
10-Q filing | 107.6M shares outstanding |
110M | 36M |
| May 15, 2024 |
10-Q filing | 107.6M shares outstanding |
110M | 36M |
| Apr 12, 2024 |
10-K filing | 107.6M shares outstanding |
110M | 36M |
| Nov 13, 2023 |
10-Q filing | 107.6M shares outstanding |
110M | 36M |
| Oct 17, 2023 |
10-Q filing | 107.6M shares outstanding |
110M | 36M |
| Oct 05, 2023 |
10-Q filing | 107.3M shares outstanding |
110M | 37M |
| Jul 18, 2023 |
10-K filing | 106.4M shares outstanding |
110M | 38M |
| Nov 30, 2022 |
8-K filing: U. S. Antimony converted 1,692,672 shares of Series D Preferred stock for 1,692,672 shares of common stock and a cash payment of approximately $787,730 for accrued dividends. |
110M | 38M |
| Nov 28, 2022 |
8-K filing: U.S. Antimony's Board of Directors approved a 5 million share stock buyback program on November 21st, 2022. |
110M | 38M |
| Nov 14, 2022 |
10-Q filing | 106.4M shares outstanding |
110M | 38M |
| Aug 16, 2022 |
10-Q filing | 106.2M shares outstanding |
110M | 38M |
| May 16, 2022 |
10-Q filing | 106.2M shares outstanding |
110M | 38M |
| Mar 31, 2022 |
10-K filing | 106.2M shares outstanding |
110M | 38M |
| Jan 27, 2022 |
S-3/A filing: The company may offer shares of common stock, preferred stock, senior debt securities, subordinated debt securities, warrants, rights and units up to an aggregate initial offering price of $25,000,000. |
110M | 38M |
| Jan 14, 2022 |
S-3 filing: The filing indicates that the company may offer shares of its common stock, preferred stock, senior debt securities, subordinated debt securities, warrants, rights and units, with an aggregate initial offering price not to exceed $25,000,000. |
110M | 31M |
| Nov 15, 2021 |
10-Q filing | 106.1M shares outstanding |
110M | 0 |
| Aug 16, 2021 |
10-Q filing | 106.3M shares outstanding |
110M | 0 |
| May 14, 2021 |
10-Q filing | 106.0M shares outstanding |
110M | 0 |
| Mar 31, 2021 |
10-K filing | 69.7M shares outstanding |
70M | 18M |
| Feb 12, 2021 |
8-K filing: United States Antimony Corporation entered into a Securities Purchase Agreement to sell 10,990,000 shares of common stock at $1.30 per share, with gross proceeds of approximately $14.3 million, in a registered direct offering. ($14.3M proceeds) |
76M | 11M |
| Jan 19, 2021 |
S-3 filing: United States Antimony Corporation is filing an S-3 to register an indeterminate number of shares of common stock and preferred stock, an indeterminate principal amount of debt securities, an indeterminate number of warrants to purchase common stock, preferred stock and/or debt securities, an indeterminate number of rights to purchase common stock or preferred stock and such indeterminate number of units as may be sold by the Registrant from time to time, which together shall have an aggregate initial offering price not to exceed $25,000,000. |
76M | 11M |
| Nov 16, 2020 |
10-Q filing | 75.9M shares outstanding |
76M | 11M |
| Sep 11, 2020 |
S-3/A filing: This S-3/A filing relates to an offering of common stock by selling stockholders, including shares issuable upon the exercise of warrants. |
76M | 11M |
| Sep 10, 2020 |
S-3/A filing: This S-3/A filing relates to an offering of common stock by selling stockholders, including shares issuable upon exercise of warrants. The company will not receive proceeds from the sale of shares but will receive proceeds from warrant exercises. |
76M | 5.7M |
| Aug 26, 2020 |
S-3 filing: This S-3 filing relates to the offering of common stock by selling stockholders, including shares issuable upon the exercise of warrants. |
76M | 11M |
| Aug 19, 2020 |
10-Q filing | 69.9M shares outstanding |
70M | 0 |
| May 15, 2020 |
10-Q filing | 69.7M shares outstanding |
70M | 0 |
| Apr 14, 2020 |
10-K filing | 69.0M shares outstanding |
69M | 0 |